What is the ticker symbol for Cidara Therapeutics?

Cidara Therapeutics trades under the ticker CDTX on NASDAQ.

What sector does Cidara Therapeutics operate in?

Cidara Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CDTX in a portfolio?

PortView shows CDTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Cidara Therapeutics (CDTX) Stock Analysis

NASDAQHealthcareBiotechnology

$221.38+0.00%

1-year price historyRange $16.43 – $221.38

52-week range$221.38

$15.22$221.42

What Cidara Therapeutics does

Cidara Therapeutics, Inc. is a biotechnology company specializing in the creation, advancement, and commercialization of extended-duration anti-infective drugs. Their mission targets the prevention and treatment of infectious diseases and certain cancers within the U.S. Their primary therapeutic candidate, rezafungin acetate, is an innovative echinocandin antifungal designed to combat and avert severe fungal infections such as candidemia and invasive candidiasis, conditions known for their high fatality rates. Additionally, Cidara utilizes its Cloudbreak platform to engineer conjugated therapies aimed at preventing and treating influenza as well as various other viral illnesses, including respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), and SARS-CoV-2, the pathogen behind COVID-19. Originally incorporated in 2012 as K2 Therapeutics, Inc., the company adopted its current name, Cidara Therapeutics, Inc., in July 2014. Its operations are headquartered in San Diego, California.

Key metrics

Market cap

$5.61B

P/E (TTM)

-19.77

EPS (TTM)

$-11.20

Beta

1.53

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$187.66

200-day avg

$84.67

52-week high

$221.42

52-week low

$15.22

CEO

Jeffrey L. Stein

ETFs linked to CDTX

Broad-market and Healthcare sector ETFs an investor holding Cidara Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CDTX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CDTX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Cidara Therapeutics?: Cidara Therapeutics trades under the ticker CDTX on NASDAQ.
Which exchange is CDTX listed on?: CDTX is listed on NASDAQ.
What sector does Cidara Therapeutics operate in?: Cidara Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CDTX in a portfolio?: PortView shows CDTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.